急性心肌梗死合并多支血管病变患者完全血运重建的临床研究进展  

Research progress on complete revascularization in patients with acute myocardial infarction complicated with multi-vessel disease

作　　者：赵宽 黄新亮 Zhao Kuan;Huang Xinliang(Department of Cardiology,San Er Ling Yi Hospital,Hanzhong 723000,Chin;Department of Cardiology,Hanzhong People s Hospital,Hanzhong 723000,China)

机构地区：[1]三二0一医院心内科,汉中723000 [2]汉中市人民医院心内科,723000

出　　处：《中国心血管杂志》2018年第4期351-353,共3页Chinese Journal of Cardiovascular Medicine

摘　　要：急性心肌梗死合并多支血管病变患者预后差,其血运重建策略的选择是介入治疗的难点。现有指南推荐,ST段抬高型心肌梗死患者急诊经皮冠状动脉介入术(PCI)时仅干预梗死相关血管,同时处理非梗死相关血管可能使患者临床预后恶化。然而随着介入器械、技术的进步和新型抗栓药物的临床应用,最近的一些研究结果提示处理非梗死相关血管可降低患者发生主要不良心脏事件的风险和改善患者预后。现就急性心肌梗死多支血管病变患者介入性完全血运重建的临床研究进展做一综述。Patients with acute myocardial infarction（AMI）complicated with multi-vessel disease are associated with poor prognosis,and the strategy of revascularization is a difficulty for imterventional therapy.The current guideline recommend that percutaneous coronary intervention（PCI）is considered only for the culprit vessel in ST segment elevation myocardial infarction（STEMI）,while clinical condition may be worse if non-culprit vessel is treated at the same time.However,with the development of the interventional device,technology and novel anticoagulant drugs,several new clinical studies suggest that intervention for the non-culprit vessel could reduce the risk of major adverse cardiac events and improve the prognosis.Therefore,latest progresses on complete revascularization for patients with AMI complicated with multi-vessel disease were summarized in this review.

关 键 词：急性心肌梗死 多支血管病变 完全血运重建 

分 类 号：R542.22[医药卫生—心血管疾病]